L Kemmis1, J K Hall, R Kingston, M J Morgan. 1. Department of Psychology, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9QG, UK.
Abstract
INTRODUCTION: The ability to read facial expressions is essential for normal human social interaction. The aim of the present study was to conduct the first investigation of facial expression recognition performance in recreational cocaine users. MATERIALS AND METHODS: Three groups, comprised of 21 cocaine naïve participants (CN), 30 occasional cocaine (OC), and 48 regular recreational cocaine (RC) users, were compared. An emotional facial expression (EFE) task consisting of a male and female face expressing six basic emotions (happiness, surprise, sadness, anger, fear, and disgust) was administered. Mean percent accuracy and latencies for correct responses across eight presentations of each basic emotion were derived. Participants were also assessed with the "Eyes task" to investigate their ability to recognize more complex emotional states and the Symptom CheckList-90-Revised to measure psychopathology. RESULTS: There were no group differences in psychopathology or "eyes task" performance, but the RC group, who otherwise had similar illicit substance use histories to the OC group, exhibited impaired fear recognition accuracy compared to the OC and CN groups. The RC group also correctly identified anger, fear, happiness, and surprise, more slowly than CN, but not OC participants. The OC group was slower than CN when correctly identifying disgust. The selective deficit in fear recognition accuracy manifested by the RC group cannot be explained by the subacute effects of cocaine, or ecstasy, because recent and less recent users of these drugs within this group were similarly impaired. Possible parallels between RC users and psychopaths with respect to impaired fear recognition, amygdala dysfunction, and etiology are discussed.
INTRODUCTION: The ability to read facial expressions is essential for normal human social interaction. The aim of the present study was to conduct the first investigation of facial expression recognition performance in recreational cocaine users. MATERIALS AND METHODS: Three groups, comprised of 21 cocaine naïve participants (CN), 30 occasional cocaine (OC), and 48 regular recreational cocaine (RC) users, were compared. An emotional facial expression (EFE) task consisting of a male and female face expressing six basic emotions (happiness, surprise, sadness, anger, fear, and disgust) was administered. Mean percent accuracy and latencies for correct responses across eight presentations of each basic emotion were derived. Participants were also assessed with the "Eyes task" to investigate their ability to recognize more complex emotional states and the Symptom CheckList-90-Revised to measure psychopathology. RESULTS: There were no group differences in psychopathology or "eyes task" performance, but the RC group, who otherwise had similar illicit substance use histories to the OC group, exhibited impaired fear recognition accuracy compared to the OC and CN groups. The RC group also correctly identified anger, fear, happiness, and surprise, more slowly than CN, but not OC participants. The OC group was slower than CN when correctly identifying disgust. The selective deficit in fear recognition accuracy manifested by the RC group cannot be explained by the subacute effects of cocaine, or ecstasy, because recent and less recent users of these drugs within this group were similarly impaired. Possible parallels between RC users and psychopaths with respect to impaired fear recognition, amygdala dysfunction, and etiology are discussed.
Authors: Nikos Makris; Gregory P Gasic; Larry J Seidman; Jill M Goldstein; David R Gastfriend; Igor Elman; Matthew D Albaugh; Steven M Hodge; David A Ziegler; Fred S Sheahan; Verne S Caviness; Ming T Tsuang; David N Kennedy; Steven E Hyman; Bruce R Rosen; Hans C Breiter Journal: Neuron Date: 2004-11-18 Impact factor: 17.173
Authors: M L Phillips; A W Young; S K Scott; A J Calder; C Andrew; V Giampietro; S C Williams; E T Bullmore; M Brammer; J A Gray Journal: Proc Biol Sci Date: 1998-10-07 Impact factor: 5.349
Authors: Patricia A Woicik; Scott J Moeller; Nelly Alia-Klein; Thomas Maloney; Tanya M Lukasik; Olga Yeliosof; Gene-Jack Wang; Nora D Volkow; Rita Z Goldstein Journal: Neuropsychopharmacology Date: 2008-05-21 Impact factor: 7.853
Authors: Samantha J Fede; Carla L Harenski; Jana Schaich Borg; Walter Sinnott-Armstrong; Vikram Rao; Brendan M Caldwell; Prashanth K Nyalakanti; Michael R Koenigs; Jean Decety; Vince D Calhoun; Kent A Kiehl Journal: Psychopharmacology (Berl) Date: 2016-07-12 Impact factor: 4.530
Authors: Katrin H Preller; Marcus Herdener; Leonhard Schilbach; Philipp Stämpfli; Lea M Hulka; Matthias Vonmoos; Nina Ingold; Kai Vogeley; Philippe N Tobler; Erich Seifritz; Boris B Quednow Journal: Proc Natl Acad Sci U S A Date: 2014-01-21 Impact factor: 11.205
Authors: Gillinder Bedi; Laura Shiffrin; Nehal P Vadhan; Edward V Nunes; Richard W Foltin; Adam Bisaga Journal: J Psychopharmacol Date: 2016-02-26 Impact factor: 4.153
Authors: Cleo L Crunelle; Anne Marije Kaag; Hanna E van den Munkhof; Liesbeth Reneman; Judith R Homberg; Bernard Sabbe; Wim van den Brink; Guido van Wingen Journal: Hum Brain Mapp Date: 2015-07-28 Impact factor: 5.038
Authors: Michael H Bernstein; Suzanne M Colby; L Cinnamon Bidwell; Christopher W Kahler; Adam M Leventhal Journal: Nicotine Tob Res Date: 2014-04-01 Impact factor: 4.244